Investigational Cell Therapy Bemdaneprocel Shows Sustained Safety and Promising Motor Improvements at 36 Months in Parkinson’s Disease Trial

Bayer AG and its subsidiary BlueRock Therapeutics LP have announced encouraging 36-month follow-up data from the Phase I exPDite clinical trial of bemdaneprocel (BRT-DA01), an investigational cell therapy aimed at…

Continue Reading Investigational Cell Therapy Bemdaneprocel Shows Sustained Safety and Promising Motor Improvements at 36 Months in Parkinson’s Disease Trial

Unlocking the Brain: CU Anschutz Uses Neuropixels Technology to Illuminate Parkinson’s Disease

Doctors and researchers at the University of Colorado Anschutz Medical Campus have achieved a groundbreaking milestone by employing advanced Neuropixels technology in the study of Parkinson’s disease. Reported by Pharmabiz.com,…

Continue Reading Unlocking the Brain: CU Anschutz Uses Neuropixels Technology to Illuminate Parkinson’s Disease

Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia

A new study published in Aging-US reveals that Parkinson’s disease (PD) patients diagnosed in their 80s are significantly more likely to exhibit amyloid-beta buildup, which is an early marker of…

Continue Reading Study Links Age to Increased Alzheimer’s-Related Brain Changes in Parkinson’s Patients Without Dementia

JCR Pharmaceuticals and Alexion Mark Key Progress in Neurodegenerative Disease Collaboration

JCR Pharmaceuticals Co., Ltd., a leader in therapies for rare and genetic diseases, has reached an important milestone in its ongoing collaboration with Alexion, AstraZeneca’s rare disease division. The achievement,…

Continue Reading JCR Pharmaceuticals and Alexion Mark Key Progress in Neurodegenerative Disease Collaboration

Parkinson’s: Newly Approved Drug Gives Advanced-Stage Patients Longer Periods of Relief

The FDA’s recent approval of AbbVie’s new combination therapy provides patients with longer-lasting control of movements. As described recently in Biopharmadive, Parkinson’s disease is characterized by uncontrolled muscle movements or…

Continue Reading Parkinson’s: Newly Approved Drug Gives Advanced-Stage Patients Longer Periods of Relief

Study shows sports-related brain injuries linked to long-term neurodegenerative diseases

Athletes experiencing multiple brain injuries now have more to worry about than ever.  Excessive traumas to the brain common in sports like boxing and football, are now being linked to…

Continue Reading Study shows sports-related brain injuries linked to long-term neurodegenerative diseases
These Nonprofits Just Shelled Out $5.2 Million to Fund An Experimental Parkinson’s Drug
source: shutterstock.com

These Nonprofits Just Shelled Out $5.2 Million to Fund An Experimental Parkinson’s Drug

According to a story from PR Newswire, the biotech company Mission Therapeutics was just awarded $5.2 million in funding to support MTX325, the company's investigational Parkinson's disease therapy. Intended to…

Continue Reading These Nonprofits Just Shelled Out $5.2 Million to Fund An Experimental Parkinson’s Drug
Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain
source: shutterstock.com

Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain

According to a story from psypost.org, a treatment approach called transcranial direct current stimulation can help alleviate certain aspects of pain associated with Parkinson's disease. Transcranial direct current stimulation (tDCS)…

Continue Reading Transcranial Direct Current Stimulation Appears Effective in Parkinson’s-Related Pain
Positive Data Suggests NT-0796 Could Benefit People with Parkinson’s Disease
https://unsplash.com/photos/8ztH-7lj8ag

Positive Data Suggests NT-0796 Could Benefit People with Parkinson’s Disease

Parkinson's disease is a progressive neurodegenerative disease. As neurons in the brain degenerate and die, those affected experience symptoms such as tremors or shaking in the hands, slowed movement, muscle…

Continue Reading Positive Data Suggests NT-0796 Could Benefit People with Parkinson’s Disease
Machine Learning Helps Identify Patterns of Progression in ALS
https://unsplash.com/photos/w7ZyuGYNpRQ

Machine Learning Helps Identify Patterns of Progression in ALS

According to a story from myscience.org, neurodegenerative diseases, such as amyotrophic lateral sclerosis, are diseases that progressively worsen over time. However, progression in this disease is not consistent across all…

Continue Reading Machine Learning Helps Identify Patterns of Progression in ALS